Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2015 1
2016 4
2017 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.
Contenti J, Guo Y, Larcher M, Mirabal-Ortega L, Rouleau M, Irondelle M, Tiroille V, Mazzu A, Duranton-Tanneur V, Pedeutour F, Ben-Sahra I, Lago C, Leva G, Tiberi L, Robert G, Pouponnot C, Bost F, Mazure NM. Contenti J, et al. Among authors: duranton tanneur v. bioRxiv [Preprint]. 2023 Oct 20:2023.10.17.562750. doi: 10.1101/2023.10.17.562750. bioRxiv. 2023. PMID: 37905067 Free PMC article. Preprint.
Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S.
Fanjat Y, Barazzutti H, Di Mauro I, Tabary-Martin L, Duranton-Tanneur V, Gimet S, Bérard H, Pedeutour F. Fanjat Y, et al. Among authors: duranton tanneur v. Cancer Genet. 2021 Aug;256-257:158-161. doi: 10.1016/j.cancergen.2021.06.001. Epub 2021 Jun 10. Cancer Genet. 2021. PMID: 34157597 Free article.
EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.
Villalva C, Duranton-Tanneur V, Guilloteau K, Burel-Vandenbos F, Wager M, Doyen J, Levillain PM, Fontaine D, Blons H, Pedeutour F, Karayan-Tapon L. Villalva C, et al. Among authors: duranton tanneur v. Cancer Med. 2013 Jun;2(3):296-304. doi: 10.1002/cam4.82. Epub 2013 Apr 23. Cancer Med. 2013. PMID: 23930206 Free PMC article.
Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.
Picard A, Pedeutour F, Peyrade F, Saudes L, Duranton-Tanneur V, Chamorey E, Cardot-Leccia N, Sudaka A, Ettaiche M, Benchetrit M, Poissonnet G, Weinbreck N, Dadone B, Lacour JP, Passeron T, Montaudié H. Picard A, et al. Among authors: duranton tanneur v. JAMA Dermatol. 2017 Apr 1;153(4):291-298. doi: 10.1001/jamadermatol.2017.0270. JAMA Dermatol. 2017. PMID: 28259104
Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.
Dequeker EM, Keppens C, Egele C, Delen S, Lamy A, Lemoine A, Sabourin JC, Andrieu C, Ligtenberg M, Fetique D, Tops B, Descarpentries C, Blons H, Denoux Y, Aube C, Penault-Llorca F, Hofman P, Leroy K, Le Marechal C, Doucet L, Duranton-Tanneur V, Pedeutour F, Soubeyran I, Côté JF, Emile JF, Vignaud JM, Monhoven N, Haddad V, Laurent-Puig P, van Krieken H, Nowak F, Lonchamp E, Bellocq JP, Rouleau E. Dequeker EM, et al. Among authors: duranton tanneur v. J Mol Diagn. 2016 Mar;18(2):205-14. doi: 10.1016/j.jmoldx.2015.09.004. Epub 2016 Jan 2. J Mol Diagn. 2016. PMID: 26752307 Free article.
[Detection of RAS genes mutation using the Cobas® method in a private laboratory of pathology: Medical and economical study in comparison to a public platform of molecular biology of cancer].
Albertini AF, Raoux D, Neumann F, Rossat S, Tabet F, Pedeutour F, Duranton-Tanneur V, Kubiniek V, Vire O, Weinbreck N. Albertini AF, et al. Among authors: duranton tanneur v. Bull Cancer. 2017 Jul-Aug;104(7-8):662-674. doi: 10.1016/j.bulcan.2017.05.005. Epub 2017 Jul 5. Bull Cancer. 2017. PMID: 28688743 French.
11 results